M&A Deal Summary |
|
---|---|
Date | 2014-05-16 |
Target | CFR Pharmaceuticals S.A. |
Sector | Life Science |
Buyer(s) | Abbott Laboratories |
Deal Type | Add-on Acquisition |
Deal Value | 2.9B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1888 |
Sector | Medical Products |
Employees | 114,000 |
Revenue | 40.1B USD (2023) |
Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 25 of 35 |
Sector (Life Science) | 10 of 11 |
Type (Add-on Acquisition) | 25 of 35 |
Country (Chile) | 1 of 1 |
Year (2014) | 1 of 3 |
Size (of disclosed) | 8 of 28 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-08-19 |
OptiMedica
Santa Clara, California, United States OptiMedica Corp. is an ophthalmic device company. |
Buy | $250M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-06-23 |
Veropharm
Moscow, Russia Veropharm is a Russian pharmaceutical producer known in Russia and abroad as one of Russia’s major manufacturers of generic drugs that are identical to their brand name counterparts, oncological medications, and medical adhesive bandages. |
Buy | $305M |